Search
for
Sort by
Research 30 of 1000+
- LPA-producing enzyme PA-PLA<sub>1</sub>α regulates hair follicle development by modulating EGFR signalling
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin
- EGFR signaling is required for regenerative proliferation in the cochlea: Conservation in birds and mammals
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Cutaneous side-effects of EGFR inhibitors and their management.
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Cutaneous consequences of inhibiting EGF receptor signaling in vivo: Normal hair follicle development, but retarded hair cycle induction and inhibition of adipocyte growth in EgfrWa5 mice
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- EGFR Controls Hair Shaft Differentiation in a p53-Independent Manner
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Epiregulin promotes hair growth via EGFR‐medicated epidermal and ErbB4‐mediated dermal stimulation
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Piperonylic Acid Promotes Hair Growth by Activation of EGFR and Wnt/β-Catenin Pathway
- Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- The urine as a diagnostic key for a homozygous EGFR mutation
- Abstract 18: Targeted epidermal ablation of EGFR causes local and systemic inflammation
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- EGFR marks a subpopulation of dermal mesenchymal cells highly expressing IGF1 which enhances hair follicle regeneration.
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung